← Open Payments lookup

IMAN HANNA: Open Payments

NPI 1831247766 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$383 in 12 payments from 7 companies in 2025. Trend: 2023 $429 · 2024 $511 · 2025 $383

Food & beverage: $383
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$104
Penumbra, Inc.1$101
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$89
Neurocrine BioSciences, Inc.1$29
Axsome Therapeutics, Inc.1$24
ABBVIE INC.1$20
Supernus Pharmaceuticals, Inc.1$17

Products named: Penumbra System, CAPLYTA, REXULTI, INGREZZA, Auvelity, VRAYLAR, Qelbree, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.